Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

RADX

Radiopharm Theranostics Limited

Healthcare · USD

Set alert

Price alert · RADX

All alert types
1.08 USD -0.04 -3.26%
As of Oct 30, 2026 Extended hours 1.08 0.00%
Bid
1.08 × 2
Ask
1.15 × 2
1.08 Day range 1.16
0.90 52-week range 10.63
YTD
-79.31%
1 year
-79.11%
Open
1.09
Prev close
1.12
Mkt cap
16.96M
Vol
8.92K
Avg vol
56.66K
EPS
-3.64
P/E
0.00
Div yield
0.00%
More statistics
Low
1.08
High
1.16
Forward P/E
0.00
Beta
0.85
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
7.67
200-d avg
7.67
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m
RADX five-day price chart0.910.950.991.031.07Oct 22Oct 23Oct 26Oct 27

Financial health

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -1.3×
FY 2021: -0.9×FY 2022: -0.8×FY 2023: -0.7×FY 2024: -1.3×FY 2025: -1.3×
FY 2021 5y median -0.9× FY 2025
P/S 26.4×
FY 2021: 2954×FY 2022: 92.5×FY 2023: 114×FY 2024: 13.5×FY 2025: 26.4×
FY 2021 5y median 92.5× FY 2025
P/B 2.9×
FY 2021: 0.4×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 1.1×FY 2025: 2.9×
FY 2021 5y median 1.1× FY 2025
P/FCF 0.0×
FY 2021: -0.7×FY 2022: -1.1×FY 2023: -1.5×FY 2024: -1.3×FY 2025: 0.0×
FY 2021 5y median -1.1× FY 2025
EV/EBITDA -1.1×
FY 2021: 0.0×FY 2022: -0.5×FY 2023: -0.4×FY 2024: -0.6×FY 2025: -1.1×
FY 2021 5y median -0.5× FY 2025
EV/Sales 24.9×
FY 2021: -101×FY 2022: 52.4×FY 2023: 52.1×FY 2024: 5.4×FY 2025: 24.9×
FY 2021 5y median 24.9× FY 2025
FCF Yield 0.0%
FY 2021: -146.6%FY 2022: -91.5%FY 2023: -67.2%FY 2024: -74.9%FY 2025: 0.0%
FY 2021 5y median -74.9% FY 2025

Profitability

Gross Margin -77.7%
FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 1.1%FY 2025: -77.7%
FY 2021 5y median 100.0% FY 2025
Operating Margin -2468.6%
FY 2021: -225527.7%FY 2022: -11803.3%FY 2023: -12238.4%FY 2024: -1050.6%FY 2025: -2468.6%
FY 2021 5y median -11803.3% FY 2025
Net Margin -1992.5%
FY 2021: -343550.9%FY 2022: -11838.6%FY 2023: -16024.3%FY 2024: -1055.3%FY 2025: -1992.5%
FY 2021 5y median -11838.6% FY 2025
ROE -218.5%
FY 2021: -48.2%FY 2022: -78.0%FY 2023: -170.5%FY 2024: -85.6%FY 2025: -218.5%
FY 2021 5y median -85.6% FY 2025
ROIC -161.9%
FY 2021: -26.4%FY 2022: -55.9%FY 2023: -67.2%FY 2024: -53.4%FY 2025: -161.9%
FY 2021 5y median -55.9% FY 2025
ROA -89.7%
FY 2021: -36.4%FY 2022: -46.2%FY 2023: -66.6%FY 2024: -44.3%FY 2025: -89.7%
FY 2021 5y median -46.2% FY 2025

Growth (YoY)

Revenue -25.5%
FY 2021: 0.0%FY 2022: 3210.6%FY 2023: 2.3%FY 2024: 1114.3%FY 2025: -25.5%
FY 2021 FY 2025
Operating Income -75.1%
FY 2021: 0.0%FY 2022: -73.3%FY 2023: -6.1%FY 2024: -4.2%FY 2025: -75.1%
FY 2021 FY 2025
EPS (diluted) 13.6%
FY 2021: 0.0%FY 2022: -10.9%FY 2023: -9.1%FY 2024: 85.3%FY 2025: 13.6%
FY 2021 FY 2025
Free Cash Flow 100.0%
FY 2021: 0.0%FY 2022: 35.3%FY 2023: 7.1%FY 2024: -59.5%FY 2025: 100.0%
FY 2021 FY 2025

Financial Health

Current Ratio 1.2×
FY 2021: 3.5×FY 2022: 1.2×FY 2023: 1.3×FY 2024: 2.7×FY 2025: 1.2×
FY 2021 5y median 1.3× FY 2025
Quick Ratio 1.2×
FY 2021: 3.5×FY 2022: 1.2×FY 2023: 1.3×FY 2024: 2.7×FY 2025: 1.2×
FY 2021 5y median 1.3× FY 2025
Debt / Equity 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2021: 1.5×FY 2022: 0.4×FY 2023: 0.4×FY 2024: 0.8×FY 2025: 0.1×
FY 2021 5y median 0.4× FY 2025
Interest Coverage -608×
FY 2021: -2.1×FY 2022: -401×FY 2023: -57.0×FY 2024: -585×FY 2025: -608×
FY 2021 5y median -401× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2026-06-30